Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A, et al. Flammer syndrome. EPMA J. 2014;5(1):11. https://doi.org/10.1186/1878-5085-5-11.

Article  PubMed  PubMed Central  Google Scholar 

Golubnitschaja-Labudova O, Liu R, Decker C, Zhu P, Haefliger IO, Flammer J. Altered gene expression in lymphocytes of patients with normal-tension glaucoma. Curr Eye Res. 2000;21(5):867–76. https://doi.org/10.1076/ceyr.21.5.867.5534.

Article  CAS  PubMed  Google Scholar 

Golubnitschaja O, Yeghiazaryan K, Flammer F. Multiomic signature of glaucoma predisposition in Flammer syndrome affected individuals – innovative predictive, preventive and personalised strategies in disease management. In the book O. Golubnitschaja (ed.), Flammer syndrome, advances in predictive, preventive and personalised medicine, Vol 11, Springer Nature Switzerland AG (2019). https://doi.org/10.1007/978-3-030-13550-8_5.

Flammer J, Pache M. Resink T (2001) Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res. 2001;20:319–49. https://doi.org/10.1016/s1350-9462(00)00028-8.

Article  CAS  PubMed  Google Scholar 

Golubnitschaja O, Flammer J. Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for predictive, preventive and personalised medicine. EPMA J. 2018;9(1):15–20. https://doi.org/10.1007/s13167-018-0127-9.

Article  PubMed  PubMed Central  Google Scholar 

Kunin A, Polivka J Jr., Moiseeva N, Golubnitschaja O. “Dry mouth” and “Flammer” syndromes-neglected risks in adolescents and new concepts by predictive, preventive and personalised approach. EPMA J. 2018;9(3):307–17. https://doi.org/10.1007/s13167-018-0145-7.

Article  PubMed  PubMed Central  Google Scholar 

Kunin A, Sargheini N, Birkenbihl C, Moiseeva N, Fröhlich H, Golubnitschaja O. Voice perturbations under the stress overload in young individuals: phenotyping and suboptimal health as predictors for cascading pathologies. EPMA J. 2020;11(4):517–27. https://doi.org/10.1007/s13167-020-00229-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goncharenko V, Bubnov R, Polivka J Jr, Zubor P, Biringer K, Bielik T, et al. Vaginal dryness: individualised patient profiles, risks and mitigating measures. EPMA J. 2019;10(1):73–9. https://doi.org/10.1007/s13167-019-00164-3.

Article  PubMed  PubMed Central  Google Scholar 

Golubnitschaja O, Liskova A, Koklesova L, Samec M, Biringer K, Büsselberg D, et al. Caution, “normal” BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021. EPMA J. 2021;12(3):243–64. https://doi.org/10.1007/s13167-021-00251-4.

Article  PubMed  PubMed Central  Google Scholar 

Evsevieva M, Sergeeva O, Mazurakova A, Koklesova L, Prokhorenko-Kolomoytseva I, Shchetinin E, et al. Pre-pregnancy check-up of maternal vascular status and associated phenotype is crucial for the health of mother and offspring. EPMA J. 2022;13(3):351–66. https://doi.org/10.1007/s13167-022-00294-1.

Article  PubMed  PubMed Central  Google Scholar 

Baban B, Golubnitschaja O. The potential relationship between Flammer and Sjogren syndromes: the chime of dysfunction. EPMA J. 2017;8(4):333–8. https://doi.org/10.1007/s13167-017-0107-5.

Article  PubMed  PubMed Central  Google Scholar 

Golubnitschaja O. Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification? EPMA J. 2017;8(1):17–22. https://doi.org/10.1007/s13167-017-0086-6.

Article  PubMed  PubMed Central  Google Scholar 

Zubor P, Gondova A, Polivka J Jr, Kasajova P, Konieczka K, Danko J, et al. Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach? EPMA J. 2017;8(2):129–40. https://doi.org/10.1007/s13167-017-0089-3.

Article  PubMed  PubMed Central  Google Scholar 

Bubnov R, Polivka J Jr., Zubor P, Konieczka K, Golubnitschaja O. Pre-metastatic niches in breast cancer: are they created by or prior to the tumour onset? Flammer syndrome relevance to address the question. EPMA J. 2017;8(2):141–57. https://doi.org/10.1007/s13167-017-0092-8.

Article  PubMed  PubMed Central  Google Scholar 

Avishai E, Yeghiazaryan K, Golubnitschaja O. Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine. EPMA J. 2017;8(1):23–33. https://doi.org/10.1007/s13167-017-0081-y.

Article  PubMed  PubMed Central  Google Scholar 

Polivka J Jr, Polivka J, Pesta M, Rohan V, Celedova L, Mahajani S, et al. Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach. EPMA J. 2019;10(1):81–99. https://doi.org/10.1007/s13167-019-00162-5.

Article  PubMed  PubMed Central  Google Scholar 

Golubnitschaja O, Potuznik P, Polivka J Jr, Pesta M, Kaverina O, Pieper CC, et al. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach. EPMA J. 2022;13(4):535–45. https://doi.org/10.1007/s13167-022-00307-z.

Article  PubMed  PubMed Central  Google Scholar 

Martuliak I, Golubnitschaja O, Chvala L, Kapalla M, Ferencik M, Bubeliny M, et al. Pain chronification risk assessment: advanced phenotyping and scoring for prediction and treatments tailored to individualized patient profile. EPMA J. 2024;15(4):739–50. https://doi.org/10.1007/s13167-024-00383-3.

Article  PubMed  PubMed Central  Google Scholar 

Chen R, Wang X, Li N, Golubnitschaja O, Zhan X. Body fluid multiomics in 3PM-guided ischemic stroke management: health risk assessment, targeted protection against health-to-disease transition, and cost-effective personalized approach are envisaged. EPMA J. 2024;15(3):415–52. https://doi.org/10.1007/s13167-024-00376-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Golubnitschaja O, Polivka J Jr, Potuznik P, Pesta M, Stetkarova I, Mazurakova A, et al. The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation. EPMA J. 2024;15(1):1–23. https://doi.org/10.1007/s13167-024-00356-6.

Article  PubMed  PubMed Central  Google Scholar 

Koklesova L, Mazurakova A, Samec M, Kudela E, Biringer K, Kubatka P, et al. Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine. EPMA J. 2022;13(2):177–93. https://doi.org/10.1007/s13167-022-00281-6.

Article  PubMed  PubMed Central  Google Scholar 

Golubnitschaja O, Kapinova A, Sargheini N, Bojkova B, Kapalla M, Heinrich L, et al. Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care-clinically relevant 3PM innovation. EPMA J. 2024;15(2):163–205. https://doi.org/10.1007/s13167-024-00358-4.

Article  PubMed  PubMed Central  Google Scholar 

Bajinka O, Ouedraogo SY, Golubnitschaja O, Li N, Zhan X. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine. EPMA J. 2024;15(2):289–319. https://doi.org/10.1007/s13167-024-00357-5.

Article  PubMed  PubMed Central  Google Scholar 

Golubnitschaja O, Sargheini N, Bastert J. Mitochondria in cutaneous health, disease, ageing and rejuvenation-the 3PM-guided mitochondria-centric dermatology. EPMA J. 2025;16(1):1–15. https://doi.org/10.1007/s13167-025-00400-z.

Article  PubMed  PubMed Central  Google Scholar 

Golubnitschaja O. What is the routine mitochondrial health check-up good for? A holistic approach in the framework of 3P medicine. In: Podbielska H, Kapalla M, eds. Predictive, preventive, and personalised medicine: From Bench to Bedside. Cham: Springer International Publishing (2023). https://link.springer.com/10.1007/978-3-031-34884-6_3.

Golubnitschaja O. Mitochondrion: the subordinated partner who agreed to come short but insists in healthy life. In: Wang W, editor. All around suboptimal health: advanced approaches by predictive, preventive and personalised medicine for healthy populations. Cham: Springer Nature Switzerland, (2024). https://doi.org/10.1007/978-3-031-46891-9_3.

Pesta M, Mrazova B, Kapalla M, Kulda V, Gkika E, Golubnitschaja O. Mitochondria-based holistic 3PM approach as the “game-changer” for individualised rehabilitation-the proof-of-principle model by treated breast cancer survivors. EPMA J. 2024;15(4):559–71. https://doi.org/10.1007/s13167-024-00386-0.

Article  PubMed  PubMed Central  Google Scholar 

Shao Q, Ndzie Noah ML, Golubnitschaja O, Zhan X. Mitochondrial medicine: “from bench to bedside” 3PM-guided concept. EPMA J. 2025;16(2):239–64.